
Loading, please wait...

Loading, please wait...

Seborrheic keratoses (SK) represent the most frequent benign epidermal tumors in clinical dermatology. Clinicians encounter these lesions daily, yet their exact pathogenesis remains a topic of active research. Recent clinical investigations identify specific seborrheic keratoses genetic factors that predispose individuals to a high lesion burden. Specifically, DNA repair gene polymorphisms play a crucial role in this biological process. Consequently, understanding these markers helps doctors categorize patient risk more effectively.
A recent study by Ciobotariu and colleagues examined the relationship between SK and polymorphisms in DNA repair genes. Researchers utilized a case-control design to evaluate patients with varying counts of these benign tumors. Notably, the rs25487 polymorphism in the XRCC1 gene demonstrated a significant association with the presence of over 50 lesions. Patients carrying this genetic variant faced more than three times the risk compared to those with fewer lesions. Moreover, this genetic susceptibility suggests that impaired DNA repair mechanisms might drive the clonal expansion of keratinocytes.
In addition to specific gene variants, environmental and phenotypic traits significantly influence the development of these tumors. Increasing age remains the most consistent epidemiological factor, as the risk rises progressively in older populations. Furthermore, the study highlighted that individuals with lighter skin types, specifically phototypes I and II, are more susceptible. Therefore, the combination of ultraviolet (UV) exposure and genetic predisposition likely creates a metabolic environment conducive to lesion development. However, clinicians should remember that these lesions remain genetically stable despite harboring numerous somatic mutations.
The association between SK and other skin conditions, such as melanoma, also warrants clinical attention. Although SKs are benign, a high lesion count may signal a broader susceptibility to UV-induced damage. Consequently, these lesions occasionally serve as markers in paraneoplastic syndromes or as indicators of extensive cumulative sun damage. Furthermore, clinicians can use these findings to provide more personalized counseling to patients regarding sun protection and long-term skin health monitoring.
Recent research indicates that the rs25487 polymorphism in the XRCC1 gene is a major factor. Individuals with this variant often present with more than 50 seborrheic keratoses during clinical examination.
Yes, skin phototypes I and II are more frequently associated with a high number of lesions. This occurs because lighter skin is generally more susceptible to damage from ultraviolet radiation.
No, despite harboring mutations like those in the FGFR3 or PIK3CA genes, seborrheic keratoses are benign. They lack the biological potential to transform into malignant skin cancers.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
1. Ciobotariu I et al. DNA Repair Gene Polymorphisms as Genetic Factors Associated with Presence of Seborrheic Keratoses. Dermatology. 2026 Mar 08. doi: 10.1159/000551368. PMID: 41795822.
2. Heidenreich B et al. Genetic alterations in seborrheic keratoses. Oncotarget. 2017 May 30;8(22):36639-36655. doi: 10.18632/oncotarget.16698.
3. Medscape. Seborrheic Keratosis: Pathophysiology and Etiology. Updated 2026. Available at: https://reference.medscape.com/article/1059477-overview.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies DNA repair gene polymorphisms, particularly in XRCC1, as significant genetic factors linked to seborrheic keratoses prevalence....
7 months ago

Recent epidemiological data reveals a dramatic surge in summer heat mortality driven by human-induced climate warming. This analysis explores the pathophysiological impacts on cardiac and renal systems, diagnostic dilemmas in death certification, and essential emergency cooling protocols for acute clinical care.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today

A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today